000 01222 a2200325 4500
005 20250515170834.0
264 0 _c20090902
008 200909s 0 0 eng d
022 _a1863-2300
024 7 _a10.1007/s00281-009-0150-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMontecucco, Fabrizio
245 0 0 _aUpdate on statin-mediated anti-inflammatory activities in atherosclerosis.
_h[electronic resource]
260 _bSeminars in immunopathology
_cJun 2009
300 _a127-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents
_ximmunology
650 0 4 _aAntioxidants
650 0 4 _aAtherosclerosis
_xdrug therapy
650 0 4 _aCholesterol
_ximmunology
650 0 4 _aDisease Models, Animal
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_ximmunology
650 0 4 _aInflammation
_xdrug therapy
650 0 4 _aSignal Transduction
_xdrug effects
700 1 _aMach, François
773 0 _tSeminars in immunopathology
_gvol. 31
_gno. 1
_gp. 127-42
856 4 0 _uhttps://doi.org/10.1007/s00281-009-0150-y
_zAvailable from publisher's website
999 _c18844204
_d18844204